Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual meeting of The Obesity Society in San Antonio.
Executive Board member Jens Ravens leaves the Company on April 30, 2024 – Biotech Investments
EQS-News: Epigenomics AG / Key word(s): Personnel Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30.04.2024 / 15:00 CET/CEST The